Since Dr. Glenn C. Rowe left the campus of MassBay in 1999, he has gone on to become one of the most accomplished scholars in the history of the institution.
Dr. Rowe studied biotechnology at MassBay from 1997-1999, receiving his Associate's degree upon graduating. He transferred his credits to Brandeis University, graduating with a Bachelor's of Science in Biology in 2001. That year, he began his advanced studies at Yale University, earning his Master's Degree in Molecular, Cellular and Developmental Biology in 2003; and his Doctor of Philosophy in Molecular, Cellular and Developmental Biology in 2007.
Throughout his academic career, Dr. Rowe has been widely acclaimed for his work. While at MassBay, Dr. Rowe earned a 1999 Barry M. Goldwater Scholarship - the highest national honor for undergraduate work in mathematics and the sciences. He was awarded the 2000 American Association for Cancer Research Minority Award; was a 2000 Ronald E. McNair Scholar; earned a 2005 UNCF Merck Graduate Science
Research Dissertation Fellowship; was awarded a 2007 Young Investigator Award from the American Society for Bone and Mineral Research; received a 2008 New Investigator Award from the European Calcified Tissue Society; and earned a 2009 UNCF Merck Postdoctoral Science Research Fellowship, under which he currently performs his duties.
Currently, Dr. Rowe is a Research Fellow in the Department of Medicine at Harvard Medical School, and in the Cardiovascular Institute at the Beth Israel Deaconess Medical Center. Dr. Rowe has been a credited author four times, currently preparing his fifth title, which will address AP-1 expression in the hypothalamus regulates both energy expenditure and bone formation in adult mice.
Dr. Rowe is an active and involved alumnus of MassBay, volunteering to serve on the Board of Trustees in March of last year. His term as a Trustee runs through 2014.